


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 7 Oct 2010
CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
HSMN NewsFeed - 5 Oct 2010
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
HSMN NewsFeed - 21 Sep 2010
PROMUS(R) Element Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries
PROMUS(R) Element Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries
HSMN NewsFeed - 21 Sep 2010
Bioconnect Systems Gains CE Mark Approval for Optiflow Anastomotic System
Bioconnect Systems Gains CE Mark Approval for Optiflow Anastomotic System
HSMN NewsFeed - 20 Sep 2010
Aeris Therapeutics Announces CE Mark Approval for the AeriSeal(R) Emphysematous Lung Sealant System
Aeris Therapeutics Announces CE Mark Approval for the AeriSeal(R) Emphysematous Lung Sealant System
HSMN NewsFeed - 16 Sep 2010
Medtronic Receives European CE Mark Approval for Deep Brain Stimulation Therapy for Refractory Epilepsy
Medtronic Receives European CE Mark Approval for Deep Brain Stimulation Therapy for Refractory Epilepsy
HSMN NewsFeed - 13 Sep 2010
Health Canada Approves Defibtech Lifeline View Automated External Defibrillator
Health Canada Approves Defibtech Lifeline View Automated External Defibrillator
HSMN NewsFeed - 7 Sep 2010
Medtronic Gains CE Mark for Enhanced CoreValve(R) Delivery Catheter System with AccuTrak Stability Layer
Medtronic Gains CE Mark for Enhanced CoreValve(R) Delivery Catheter System with AccuTrak Stability Layer
HSMN NewsFeed - 7 Sep 2010
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
HSMN NewsFeed - 26 Aug 2010
Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
HSMN NewsFeed - 20 Aug 2010
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
